1-20 of 24
Susan Groshen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory B-Cell Lymphoma

Joseph M. Tuscano, Emanual Maverakis, Susan Groshen, Denice Tsao-Wei, Guillaume Luxardi, Alexander A. Merleev, Anne Beaven, John F. DiPersio, Leslie Popplewell, Robert Chen, Mark Kirschbaum, Mark A. Schroeder, Edward M. Newman
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (23): 7004–7013.
https://doi.org/10.1158/1078-0432.CCR-19-0438
Published: 02 December 2019
View articletitled, A Phase I Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory B-Cell Lymphoma
Open the PDF for A Phase I Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory B-Cell Lymphoma in another window
Includes: Supplementary data
Journal Articles

Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma

Kevin R. Kelly, Jonathan W. Friedberg, Steven I. Park, Kevin McDonagh, John Hayslip, Daniel Persky, Jia Ruan, Soham Puvvada, Peter Rosen, Swaminathan Padmanabhan Iyer, Alexandra Stefanovic, Steven H. Bernstein, Steven Weitman, Anand Karnad, Gregory Monohan, Ari VanderWalde, Raul Mena, Monika Schmelz, Catherine Spier, Susan Groshen, Karthik Venkatakrishnan, Xiaofei Zhou, Emily Sheldon-Waniga, E. Jane Leonard, Daruka Mahadevan
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (24): 6150–6159.
https://doi.org/10.1158/1078-0432.CCR-18-0286
Published: 13 December 2018
View articletitled, Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma
Open the PDF for Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma in another window
Includes: Supplementary data
Journal Articles

Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma

Steven G. DuBois, Yael P. Mosse, Elizabeth Fox, Rachel A. Kudgus, Joel M. Reid, Renee McGovern, Susan Groshen, Rochelle Bagatell, John M. Maris, Clare J. Twist, Kelly Goldsmith, M. Meaghan Granger, Brian Weiss, Julie R. Park, Margaret E. Macy, Susan L. Cohn, Greg Yanik, Lars M. Wagner, Randall Hawkins, Jesse Courtier, Hollie Lai, Fariba Goodarzian, Hiroyuki Shimada, Najee Boucher, Scarlett Czarnecki, Chunqiao Luo, Denice Tsao-Wei, Katherine K. Matthay, Araz Marachelian
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (24): 6142–6149.
https://doi.org/10.1158/1078-0432.CCR-18-1381
Published: 13 December 2018
View articletitled, Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma
Open the PDF for Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma in another window
Includes: Supplementary data
Journal Articles

Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis

Araz Marachelian, Judith G. Villablanca, Cathy W. Liu, Betty Liu, Fariba Goodarzian, Hollie A. Lai, Hiroyuki Shimada, Hung C. Tran, Jaime A. Parra, Richard Gallego, Nora Bedrossian, Sabrina Young, Scarlett Czarnecki, Rebekah Kennedy, Brian D. Weiss, Kelly Goldsmith, Meaghan Granger, Katherine K. Matthay, Susan Groshen, Shahab Asgharzadeh, Richard Sposto, Robert C. Seeger
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (18): 5374–5383.
https://doi.org/10.1158/1078-0432.CCR-16-2647
Published: 14 September 2017
View articletitled, Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis
Open the PDF for Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis in another window
Includes: Supplementary data
Journal Articles

Phase I Study of Fenretinide Delivered Intravenously in Patients with Relapsed or Refractory Hematologic Malignancies: A California Cancer Consortium Trial

Ann M. Mohrbacher, Allen S. Yang, Susan Groshen, Shivaani Kummar, Martin E. Gutierrez, Min H. Kang, Denice Tsao-Wei, C. Patrick Reynolds, Edward M. Newman, Barry J. Maurer
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (16): 4550–4555.
https://doi.org/10.1158/1078-0432.CCR-17-0234
Published: 14 August 2017
View articletitled, Phase I Study of Fenretinide Delivered Intravenously in Patients with Relapsed or Refractory Hematologic Malignancies: A California Cancer Consortium Trial
Open the PDF for Phase I Study of Fenretinide Delivered Intravenously in Patients with Relapsed or Refractory Hematologic Malignancies: A California Cancer Consortium Trial in another window
Includes: Supplementary data
Journal Articles

Impact of the 2010 Consensus Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee

Lesley Seymour, Susan Groshen, Gary L. Rosner, Daniel M. Sullivan, David R. Spriggs, Steven Reeves, Amy Gravell, S. Percy Ivy, Mark J. Ratain
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (22): 5057–5063.
https://doi.org/10.1158/1078-0432.CCR-15-0035
Published: 12 November 2015
View articletitled, Impact of the 2010 Consensus Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee
Open the PDF for Impact of the 2010 Consensus Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee in another window
Journal Articles

Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma

Steven G. DuBois, Susan Groshen, Julie R. Park, Daphne A. Haas-Kogan, Xiaodong Yang, Ethan Geier, Eugene Chen, Kathy Giacomini, Brian Weiss, Susan L. Cohn, M. Meaghan Granger, Gregory A. Yanik, Randall Hawkins, Jesse Courtier, Hollie Jackson, Fariba Goodarzian, Hiroyuki Shimada, Scarlett Czarnecki, Denice Tsao-Wei, Judith G. Villablanca, Araz Marachelian, Katherine K. Matthay
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (12): 2715–2721.
https://doi.org/10.1158/1078-0432.CCR-14-3240
Published: 14 June 2015
View articletitled, Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma
Open the PDF for Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma in another window
Includes: Supplementary data
Journal Articles

Phase I, Dose-Escalation Study of the Targeted Cytotoxic LHRH Analog AEZS-108 in Patients with Castration- and Taxane-Resistant Prostate Cancer

Stephen V. Liu, Denice D. Tsao-Wei, Shigang Xiong, Susan Groshen, Tanya B. Dorff, David I. Quinn, Yu-Chong Tai, Juergen Engel, Debra Hawes, Andrew V. Schally, Jacek K. Pinski
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (24): 6277–6283.
https://doi.org/10.1158/1078-0432.CCR-14-0489
Published: 14 December 2014
View articletitled, Phase I, Dose-Escalation Study of the Targeted Cytotoxic LHRH Analog AEZS-108 in Patients with Castration- and Taxane-Resistant Prostate Cancer
Open the PDF for Phase I, Dose-Escalation Study of the Targeted Cytotoxic LHRH Analog AEZS-108 in Patients with Castration- and Taxane-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Design of Phase I Combination Trials: Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee

Channing J. Paller, Penelope A. Bradbury, S. Percy Ivy, Lesley Seymour, Patricia M. LoRusso, Laurence Baker, Larry Rubinstein, Erich Huang, Deborah Collyar, Susan Groshen, Steven Reeves, Lee M. Ellis, Daniel J. Sargent, Gary L. Rosner, Michael L. LeBlanc, Mark J. Ratain
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (16): 4210–4217.
https://doi.org/10.1158/1078-0432.CCR-14-0521
Published: 13 August 2014
View articletitled, Design of Phase I Combination Trials: Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee
Open the PDF for Design of Phase I Combination Trials: Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee in another window
Journal Articles

Phase I Study of Vincristine, Irinotecan, and 131I-Metaiodobenzylguanidine for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial

Steven G. DuBois, Louis Chesler, Susan Groshen, Randall Hawkins, Fariba Goodarzian, Hiroyuki Shimada, Greg Yanik, Michael Tagen, Clinton Stewart, Yael P. Mosse, John M. Maris, Denice Tsao-Wei, Araz Marachelian, Judith G. Villablanca, Katherine K. Matthay
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (9): 2679–2686.
https://doi.org/10.1158/1078-0432.CCR-11-3201
Published: 30 April 2012
View articletitled, Phase I Study of Vincristine, Irinotecan, and 131I-Metaiodobenzylguanidine for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial
Open the PDF for Phase I Study of Vincristine, Irinotecan, and 131I-Metaiodobenzylguanidine for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial in another window
Includes: Supplementary data
Journal Articles

Portable Filter-Based Microdevice for Detection and Characterization of Circulating Tumor Cells

Henry K. Lin, Siyang Zheng, Anthony J. Williams, Marija Balic, Susan Groshen, Howard I. Scher, Martin Fleisher, Walter Stadler, Ram H. Datar, Yu-Chong Tai, Richard J. Cote
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (20): 5011–5018.
https://doi.org/10.1158/1078-0432.CCR-10-1105
Published: 13 October 2010
View articletitled, Portable Filter-Based Microdevice for Detection and Characterization of Circulating Tumor Cells
Open the PDF for Portable Filter-Based Microdevice for Detection and Characterization of Circulating Tumor Cells in another window
Journal Articles

Expression of Receptors for Luteinizing Hormone-Releasing Hormone (LH-RH) in Prostate Cancers following Therapy with LH-RH Agonists

Stephen V. Liu, Andrew V. Schally, Debra Hawes, Shigang Xiong, Laden Fazli, Martin Gleave, Jie Cai, Susan Groshen, Frank Brands, Juergen Engel, Jacek Pinski
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (18): 4675–4680.
https://doi.org/10.1158/1078-0432.CCR-10-1113
Published: 14 September 2010
View articletitled, Expression of Receptors for Luteinizing Hormone-Releasing Hormone (LH-RH) in Prostate Cancers following Therapy with LH-RH Agonists
Open the PDF for Expression of Receptors for Luteinizing Hormone-Releasing Hormone (LH-RH) in Prostate Cancers following Therapy with LH-RH Agonists in another window
Journal Articles

Guidelines for the Development and Incorporation of Biomarker Studies in Early Clinical Trials of Novel Agents

Janet E. Dancey, Kevin K. Dobbin, Susan Groshen, J. Milburn Jessup, Andrew H. Hruszkewycz, Maria Koehler, Ralph Parchment, Mark J. Ratain, Lalitha K. Shankar, Walter M. Stadler, Lawrence D. True, Amy Gravell, Michael R. Grever
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (6): 1745–1755.
https://doi.org/10.1158/1078-0432.CCR-09-2167
Published: 14 March 2010
View articletitled, Guidelines for the Development and Incorporation of Biomarker Studies in Early Clinical Trials of Novel Agents
Open the PDF for Guidelines for the Development and Incorporation of Biomarker Studies in Early Clinical Trials of Novel Agents in another window
Journal Articles

The Design of Phase II Clinical Trials Testing Cancer Therapeutics: Consensus Recommendations from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee

Lesley Seymour, S. Percy Ivy, Daniel Sargent, David Spriggs, Laurence Baker, Larry Rubinstein, Mark J. Ratain, Michael Le Blanc, David Stewart, John Crowley, Susan Groshen, Jeffrey S. Humphrey, Pamela West, Donald Berry
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (6): 1764–1769.
https://doi.org/10.1158/1078-0432.CCR-09-3287
Published: 14 March 2010
View articletitled, The Design of Phase II Clinical Trials Testing Cancer Therapeutics: Consensus Recommendations from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee
Open the PDF for The Design of Phase II Clinical Trials Testing Cancer Therapeutics: Consensus Recommendations from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee in another window
Journal Articles

Impact of Gene Polymorphisms on Clinical Outcome for Stage IV Melanoma Patients Treated with Biochemotherapy: An Exploratory Study

Dongxin Liu, Steven J. O'Day, Dongyun Yang, Peter Boasberg, Robert Milford, Tim Kristedja, Susan Groshen, Jeffrey Weber
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (3): 1237–1246.
https://doi.org/10.1158/1078-0432.1237.11.3
Published: 11 February 2005
View articletitled, Impact of Gene Polymorphisms on Clinical Outcome for Stage IV Melanoma Patients Treated with Biochemotherapy: An Exploratory Study
Open the PDF for Impact of Gene Polymorphisms on Clinical Outcome for Stage IV Melanoma Patients Treated with Biochemotherapy: An Exploratory Study in another window
Journal Articles

Concepts for Banking Tissue in Urologic Oncology—The International Bladder Cancer Bank

Peter J. Goebell, Susan Groshen, Bernd J. Schmitz-Dräger, Richard Sylvester, Manolis Kogevinas, Núria Malats, Guido Sauter, H. Barton Grossman, Colin P.N. Dinney, Fred Waldman, Richard J. Cote
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (2): 413–415.
https://doi.org/10.1158/1078-0432.413.11.2
Published: 08 February 2005
View articletitled, Concepts for Banking Tissue in Urologic Oncology—The International Bladder Cancer Bank
Open the PDF for Concepts for Banking Tissue in Urologic Oncology—The International Bladder Cancer Bank in another window
Journal Articles

Epidermal Growth Factor Receptor Gene Polymorphisms Predict Pelvic Recurrence in Patients with Rectal Cancer Treated with Chemoradiation

Wu Zhang, David J. Park, Bo Lu, Dong Yun Yang, Michael Gordon, Susan Groshen, Jim Yun, Oliver A. Press, Daniel Vallböhmer, Katrin Rhodes, Heinz-Josef Lenz
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (2): 600–605.
https://doi.org/10.1158/1078-0432.600.11.2
Published: 08 February 2005
View articletitled, Epidermal Growth Factor Receptor Gene Polymorphisms Predict Pelvic Recurrence in Patients with Rectal Cancer Treated with Chemoradiation
Open the PDF for Epidermal Growth Factor Receptor Gene Polymorphisms Predict Pelvic Recurrence in Patients with Rectal Cancer Treated with Chemoradiation in another window
Journal Articles

A Phase I Trial of SD-9427 (Progenipoietin) with a Multipeptide Vaccine for Resected Metastatic Melanoma

Vinod Pullarkat, Peter P. Lee, Ronaldo Scotland, Valerie Rubio, Susan Groshen, Conway Gee, Roy Lau, Jolie Snively, Shirley Sian, Susan L. Woulfe, Richard A. Wolfe, Jeffrey S. Weber
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (4): 1301–1312.
Published: 01 April 2003
View articletitled, A Phase I Trial of SD-9427 (Progenipoietin) with a Multipeptide Vaccine for Resected Metastatic Melanoma
Open the PDF for A Phase I Trial of SD-9427 (Progenipoietin) with a Multipeptide Vaccine for Resected Metastatic Melanoma in another window
Journal Articles

Quantitative O 6 - Methylguanine DNA Methyltransferase Methylation Analysis in Curatively Resected Non-Small Cell Lung Cancer: Associations with Clinical Outcome

Jan Brabender, Henning Usadel, Ralf Metzger, Paul M. Schneider, JiMin Park, Dennis Salonga, Denise D. Tsao-Wei, Susan Groshen, Reginald V. Lord, Naoko Takebe, Sylke Schneider, Arnulf H. Hölscher, Kathleen D. Danenberg, Peter V. Danenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (1): 223–227.
Published: 01 January 2003
View articletitled, Quantitative O 6 - Methylguanine DNA Methyltransferase Methylation Analysis in Curatively Resected Non-Small Cell Lung Cancer: Associations with Clinical Outcome
Open the PDF for Quantitative O 6 - Methylguanine DNA Methyltransferase Methylation Analysis in Curatively Resected Non-Small Cell Lung Cancer: Associations with Clinical Outcome in another window
Journal Articles

P7 Antigen Expression in Human Breast Cancer

Xiaowei Yang, Susan Groshen, Silvia C. Formenti, Nancy E. Davidson, Michael F. Press
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (1): 201–206.
Published: 01 January 2003
View articletitled, P7 Antigen Expression in Human Breast Cancer
Open the PDF for P7 Antigen Expression in Human Breast Cancer in another window